DV
Dividend Vision

ACAD — ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. (ACAD)

Total return is 321.5% over the past 22.2 years, 613.8 points behind SPY at 935.3%. Its deepest 1-year drawdown was 27.6%.

ACADIA Pharmaceuticals Inc. is a healthcare equity stock focused on the development and commercialization of pharmaceutical products. The company does not currently pay dividends, making it unsuitable for income-focused investors seeking regular distributions. This holding appeals primarily to growth-oriented investors interested in the pharmaceutical and biotechnology sector.

ACAD key facts

Asset type
Stock
Asset class
Equity
Inception date
05/27/2004
Distribution frequency
None
Last close
$28.24
Market cap
$4,865,907,712
Average volume
1062600.0
Beta
0.845
Payout ratio
0.0
P/E ratio
12.6637
Forward P/E
71.4286
EPS
$2.23